hotspot -WSS

hotspot

author：entertainment 2025-09-03 03:21:44 - browse：7

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Extensive review finds private equity owners jack up cost of care

hotspot

WSS

Ohioans vote in high

Judge denies Trump's request for new trial in E. Jean Carroll case

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Lessons Learned: This is why you network to find that industry job you want

There’s a way to spot data fakery. All journals should be using it

Hormonal contraceptives don’t actually treat endometriosis

Wikipedia

hotspot

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Scientists grapple with ethics of stem cell research

Affirmative action in medical school literally saved lives

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

In age of alternative facts, a scholarly course on calling out crap

Sanders wants to replace patents with prizes for drug inventions

The cancer drug shortage isn’t new — and neither are the solutions

CDC launches VaccineFinder tool to locate Covid

Malaria cases in Florida and Texas: Here’s what you need to know

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

hotspot

Sanders wants to replace patents with prizes for drug inventions

A year after a Russian missile took her leg, a young Ukrainian gymnast's spirit endures

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Scientists grapple with ethics of stem cell research

More regulation could be coming for drug ads

When a patient nears the end, a feared therapy can comfort

hotspot

hotspot

entertainment

focus